There were no differences between the groups in terms of gender, rates of systemic arterial hypertension (SAH) and diabetes mellitus (DM), time on dialysis, number of human leukocyte antigen (HLA)-A, HLA-B, and HLA-DR mismatches, percentages of panel reactivity antibodies, expanded criteria donors, and cold ischemia time. The gene discussed is HLA-A; the disease is diabetes mellitus.